National CineMedia Insider Sells 2,584 Shares; Prior Sale of 9,038 Reported
Rhea-AI Filing Summary
Form 144 filing for National CineMedia, Inc. (NCMI) notifies the SEC of a proposed sale of 2,584 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $12,635.76 and an approximate sale date of 09/17/2025 on NASDAQ. The shares were acquired as restricted stock units on 06/30/2025 and were fully issued on that date. The filing also discloses a prior sale by the same person of 9,038 shares on 06/30/2025 that generated gross proceeds of $43,542.37. The notice includes the required representation that the seller is not aware of undisclosed material adverse information about the issuer.
Positive
- Filing discloses proposed sale of 2,584 shares
- Prior sale of 9,038 shares on 06/30/2025 is reported with gross proceeds
- Broker for the proposed sale is identified: Morgan Stanley Smith Barney LLC
- Securities origin is documented as Restricted Stock Units vested on 06/30/2025
Negative
- Insider selling activity is disclosed and may be perceived negatively by some investors
Insights
TL;DR: Small insider selling of restricted stock units; limited market impact given modest size.
The filing reports a proposed sale of 2,584 common shares valued at $12,635.76 and a prior sale of 9,038 shares generating $43,542.37. Both transactions are relatively small versus typical public float metrics for listed companies, suggesting low immediate pressure on share liquidity or valuation. The shares were RSUs issued on 06/30/2025, indicating these sales likely reflect post-vesting liquidity rather than a change in control or financing need. From a quantitative standpoint, the disclosed amounts are unlikely to be material to company financials.
TL;DR: Filing demonstrates compliance with Rule 144 and transparency around insider transactions.
The document identifies the broker (Morgan Stanley Smith Barney LLC), the sale date window (09/17/2025), and origin of the securities (RSUs dated 06/30/2025). It also records a recent sale on 06/30/2025, meeting disclosure expectations for insider sales. The signer affirms no undisclosed material adverse information, which is the standard attestation on Form 144. There is no indication in the filing of unusual trading arrangements or 10b5-1 plan adoption dates.